The aim of the present paper is to evaluate the absorption of fumonisin B, and its principal metabolite, aminopentol on a human intestinal model, Caco-2 cells, cultured on semi-permeable inserts, that reproduces the two different intestinal compartments: luminal (apical) and serosal (basolateral) side. Following separate exposure in apical and in basolateral compartments, aminopentol passage through the cell layer (in particular from basolateral to apical direction) was shown, while it was not observed for the parent compound. The different aminopentol distribution between the two compartments of the culture system, and its variation in presence of verapamil or probenecid (P-gp and MRP inhibitors respectively), strongly suggests the involvement of P-glycoprotein in the influx/efflux mechanisms of aminopentol in the intestinal cells, reducing its oral bioavailability. (C) 2004 Elsevier Ltd. All rights reserved.
|Titolo:||Absorption of Fumonisin B-1 and aminopentol on an in vitro model of intestinal epithelium; the role of P-glycoprotein|
|Parole Chiave:||Aminopentol; Caco-2 cell line; Fumonisin B1; Intestinal absorption; P-gp|
|Settore Scientifico Disciplinare:||Settore VET/07 - Farmacologia e Tossicologia Veterinaria|
|Data di pubblicazione:||2005|
|Digital Object Identifier (DOI):||10.1016/j.toxicon.2004.10.015|
|Appare nelle tipologie:||01 - Articolo su periodico|